Society of Breast Imaging (SBI)

The core purpose of the Society of Breast Imaging (SBI) is to save lives and minimize the impact of breast cancer. SBI says it is a champion for the science of breast health, scientific integrity in women's health and fosters collaboration among breast imagers. SBI works closely with the American College of Radiology (ACR) on many policies and issues regarding mammography.

RSS icon
  • Debra L. Monticciolo, MD, FACR, FSBI, past-president of both the Society of Breast Imaging (SBI), and the American College of Radiology (ACR), explains the current recommendations and a study she did looking at real patient data and projected outcomes using different screening parameters.

    The debate over when women should start breast screenings

    Debra Monticciolo, MD, who has previously led both the Society of Breast Imaging and the American College of Radiology, discussed how different screening strategies may impact patient outcomes.

  • Telemammography

    4 key trends in breast imaging

    These trends include growth in 3D mammography, supplemental imaging for women with dense breasts and in the role of artificial intelligence.

  • Breast screening mammogram during the COVID pandemic. COVID significantly impacted breast imaging. Image courtesy of Novant Health

    VIDEO: Impact of COVID on breast imaging

    Connie Lehman, MD, PhD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at the Massachusetts General Hospital, discusses the challenges of the COVID-19 pandemic on breast screenings, increased cancer rates and issues with the vaccines causing false positives on mammograms.

  • Society of Breast Imaging (SBI) President John Lewin, MD, explains some of new initiatives and technology in mammography to increase earlier breast cancer detection. #SBI #breastimaging #mammography

    VIDEO: SBI president outlines trends in breast imaging

    Society of Breast Imaging President John Lewin, MD, explains some of the new initiatives and technology in mammography that are designed to increase early breast cancer detection.

  • Interview with Stamatia Destounis, MD, FACR, a radiologist and managing partner at Elizabeth Wende Breast Care in Rochester, New York, chair of the American College of Radiology (ACR) Breast Commission, serves on the Public Information Advisors Committee for Radiological Society of North America (RSNA) and on the Society of Breast Imaging (SBI) Communication Committee. She discusses post-COVID economic issues facing breast imaging centers, including the "great resignation" and lower reimbursements.

    VIDEO: Issues with the great resignation and lower reimbursements in breast imaging

    Stamatia Destounis, MD, FACR, a radiologist and managing partner at Elizabeth Wende Breast Care in Rochester, New York, and chair of the ACR Breast Commission, discusses post-COVID-19 economic issues facing breast imaging centers, including staffing problems from the "Great Resignation" and lower reimbursements. 

Comparison of a 2D digital mammogram and breast tomosynthesis 3D mammography from UCSF.

ACR & SBI: Mammo not dangerous to thyroid

In response to an erroneous media report, the American College of Radiology (ACR) and the Society of Breast Imaging (SBI) released a joint statement urging patients to disregard trumped up risks of thyroid cancer due to mammography-induced radiation.

Displaying 25 - 25 of 25

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.